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Abstract
Background: Very few studies have investigated the relationship between malnutrition and psychological symptoms in
Anorexia Nervosa (AN). They have used only body weight or body mass index (BMI) for the nutritional assessment and did
not always report on medication, or if they did, it was not included in the analysis of results, and they did not include
confounding factors such as duration of illness, AN subtype or age. The present study investigates this relationship using
indicators other than BMI/weight, among which body composition and biological markers, also considering potential
confounders related to depression and anxiety.
Methods: 155 AN patients, (DSM-IV) were included consecutively upon admission to inpatient treatment. Depression,
anxiety, obsessive behaviours and social functioning were measured using various scales. Nutritional status was measured
using BMI, severity of weight loss, body composition, and albumin and prealbumin levels.
Results: No correlation was found between BMI at inclusion, fat-free mass index, fat mass index, and severity of weight loss
and any of the psychometric scores. Age and medication are the only factors that affect the psychological scores. None of the
psychological scores were explained by the nutritional indicators with the exception of albumin levels which was negatively
linked to the LSAS fear score (p = 0.024; beta =20.225). Only the use of antidepressants explained the variability in BDI scores
(p = 0.029; beta = 0.228) and anxiolytic use explained the variability in HADs depression scores (p = 0.037; beta = 0.216).
Conclusion: The present study is a pioneer investigation of various nutritional markers in relation to psychological
symptoms in severely malnourished AN patients. The clinical hypothesis that malnutrition partly causes depression and
anxiety symptoms in AN in acute phase is not confirmed, and future studies are needed to back up our results.
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Introduction
The severely malnourished and disturbed biochemical status of
patients with Anorexia Nervosa (AN) [1] is a fundamental clinical
and somatic aspect of the disorder. Clinical consensus agrees that
psychological disturbances in AN patients, such as depression and
anxiety symptoms, are partly complications of malnutrition [2].
Several hypotheses and mechanisms have been proposed to
explain this impact; studies have shown implications of the
serotonergic system in mood and depression symptoms; starved
AN patients might be having low tryptophan intake, the precursor
of serotonin, which is affecting their mood [3,4]. Another
hypothesis is the effect of low leptin levels in AN due to low
adiposity [5], shown to have functional role in depression [6]
anxiety and cognitive behaviour [7,8]. Another approach is related
to vitamins and minerals deficiencies and their replenishment. In
fact, almost all vitamins have key roles in the brain functions and
the nervous system. In the same time, vitamins deficiencies are
very common and chronic in AN patients [9]. Other various
theories have arisen concerning macronutrients intake, specifically
carbohydrates and low carbohydrates diets affecting the mood and
creating depression-like symptoms [10]. AN patients, tend to have
very low carbohydrates diets and low fat diets, which might affect
negatively their mood on the long term.
Despite this implication of malnutrition in the appearance of
anxiety and depressive symptoms, [11] evidence-based data on this
relationship in AN is still very scarce [12]. We recently reviewed all
the studies that investigated this relationship in AN. Some simply
observed an improvement in psychological condition during
nutrition rehabilitation, while the others reported inconsistent
findings with no correlation between malnutrition (weight/BMI)
and psychological symptoms. Three limitations were found across
most of the studies reviewed. Firstly, they used only body weight or
body mass index (BMI) for the nutritional assessment [4–7].
Secondly, they did not always report on medication, or if they did,
it was not included in the analysis of results. Lastly, they did not
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include confounding factors such as duration of illness, AN
subtype or age. In fact the duration of the illness itself can lead to
depressive symptoms, as in any chronic disease [13].
Nutritional assessment cannot be based solely on BMI or body
weight [14]. The limitations of these methods of nutritional
assessment have been outlined in our recent review. Although
BMI is a widely accepted screening tool for obesity, its specificity
and sensitivity in undernutrition are unknown [15]. In cases of
severe malnutrition, body weight alone, like many other useful
screening tools, is not sufficiently sensitive to determine nutritional
status [9,10]. Moreover, in children and adolescents, BMI should
be used with caution, as it is relative to age; for instance a BMI of
17.5 would be on the 3rd percentile for a 19-year-old but on the
50th percentile for an 11-year old [16]. To our knowledge, no
previous studies have investigated malnutrition using other
indicators than BMI or weight, such as body composition
components (fat mass and fat-free mass) and biological markers
(albumin and prealbumin) and their relationship with the
psychological status of AN patients, also considering factors
related to depression and anxiety.
Several debatable questions arise following the above introduc-
tion: 1) Would body composition components such as fat mass and
fat free mass or biological markers tell us more about the
relationship between the nutritional status of AN patients and
depression and anxiety symptoms? 2) Are psychological symptoms
directly related to nutritional status markers? Therefore, we
hypothesis that 1) Depression and anxiety symptoms present in
AN patient at admission to inpatient treatment are related to the
severity of malnutrition, to the intensity of weight loss before
admission and to the duration of illness. 2) Body composition and
biological markers describe better the nutritional status compared
to BMI and might be linked to the psychological symptoms. Thus
the aim of the present study is to investigate, among severe AN
subjects admitted to inpatient treatment units, the link between
nutritional status evaluated by 3 different parameters (BMI, body
composition and biological markers) and the severity of depressive,
anxiety, OCD and social phobia symptoms, adjusting for
confounding factors such as duration of illness, AN subtype and
medication.
Methods
Ethics Statement
This study was part of a larger study named EVHAN
(evaluation of hospitalisation for AN, also named in French
EVALHOSPITAM, Eudract number: 2007-A01110-53, regis-
tered in Clinical trials). This study protocol was approved by the
Ile-de-France III Ethics Committee and the CNIL (Commission
nationale de l’informatique et des liberte´s). Written informed
consent was obtained from each patient before inclusion in
accordance with the declaration of Helsinki.
Subjects
One hundred and fifty-five consecutive female AN patients were
included in this study between April 2009 and May 2011. The
patients were recruited from the inpatient treatment facilities of 11
centres in France (CHU- Bordeaux, Cochin – Maison des
Adolescents, Institut Mutualiste Montsouris, MGEN – La
Verrie`re, CHU-Nantes, CHU-Rouen, Robert Debre Hospital,
Sainte-Anne Hospital, Saint-Etienne Hospital, Villejuif – Paul
Brousse). Current AN diagnosis was based on the DSM-IV criteria
obtained by the Eating Disorder Examination (EDE) [17] and the
CIDI 3.0 with the following BMI criteria: BMI ,10th percentile
up to 17 years of age, and BMI,17.5 for 17 years of age and
above [18].
At inclusion, four patients did not have a BMI,17.5. However
2 of them went from a BMI above the 97th percentile, to a BMI on
the 10th percentile relative to their age in the year preceding
hospitalization. The remaining 2 had a BMI,17.5 in the previous
three months but were initially admitted to medicine wards, and
had gained weight just before their transfer to the psychiatry unit
and inclusion in the study. Three patients did not meet DSM_IV
AN criterion D (amenorrhea, i.e. the absence of at least three
consecutive menstrual cycles), but they reported irregularity in the
cycles. In fact, amenorrhea is no longer a required criterion for AN
diagnosis (DSM V) [19].
The overall assessment investigated different aspects concerning
patient psychiatric/psychological and somatic status at admission
to inpatient treatment. All the assessments were performed in the
hospitals in the first 2 weeks after hospitalization.
Assessments
1 Psychological evaluation. The Beck Depression Inventory
(BDI), a self-rating scale of 21 items assesses cognitive and
motivational symptoms of depression at the time of evaluation
[20,21].
The Hospital Anxiety and Depression scale (HADs) is a self-
report scale rating 14 items, which assesses the most frequent
anxiety and depression symptoms. It also evaluates their severity,
taking somatic aspects that might affect the rating into account
[22,23].
The Liebowitz Social Anxiety Scale (LSAS) is a clinical
interview divided into 2 sets of questions concerning current fear
and avoidance in social interaction and performance-oriented
situations [24].
The Maudsley Obsessive Compulsive Inventory (MOCI) is a
self-report questionnaire designed to assess obsessive-compulsive
behavior using 30 items in true/false format classified in 4 sub-
scales (Checking compulsions, Washing/cleaning compulsions,
Slowness, Doubting) [25,26].
2 Nutritional assessment. Anthropometry: Body weight
was measured with standard balance beam scales (SECA,
Germany) to the nearest 0.1 kg in underwear. The subject stood
squarely on the scales not touching anything. Height was
measured with a stadiometer (SECA, Germany) to the nearest
0.1 cm. with the subject standing with heels together, arms to the
sides, legs straight, shoulders relaxed and head in the horizontal
plane (‘‘look straight ahead’’).
N The BMI in Kg/m2 was calculated as the weight in kilograms
divided by the height in meters, squared.
N Severity of weight loss: estimated as the difference between the
maximum BMI before illness and BMI at inclusion.
Body composition by bioelectrical impedance (BIA): Body
composition was assessed in the first 2 weeks of admission allowing
a time-lapse for the stabilization of fluid and electrolyte status,
likely to be affected by abnormal behaviors such as vomiting,
purging, and diuretic abuse [27,28]. The principles for measure-
ment of body composition by BIA have been previously described
by Kyle et al. [29]. BIA was measured using the Bioelectrical
Analyzer (FORANA, Helios, Frankfurt, Germany) with an
alternating electric current at 50 kHz and 800 mAmp and 4 skin
electrodes (BIANOSTIC, DataInput, Darmstadt, Germany) posi-
tioned on the right wrist and ankle. The patient was lying in the
supine position on a bed for the analysis and the skin was cleaned
Anorexia Nervosa
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with 70% alcohol for better conductance. Resistance (R) and
Reactance (Xc) in Ohms were determined.
Choice of BIA equation: We recently compared 5 BIA
equations validated in normal populations with DXA (Dual- X-
ray absorptiometry) in AN population [30]. We found that the
Deurenberg equation [31] gave the better estimates of fat mass
(FM) and fat free mass (FFM) compared to DXA, the reference
method:
FFM~{12:44z0:34 Ht2=R50z0:1534  height
z0:273  weight{0:127  age
z4:56  sex(men~1,women~0)
FM and FFM indices (FMI and FFMI): Usually, the percentage
of body fat is used to adjust fat to bodyweight; However 2
individuals with different percentages of fat mass can have either
identical FFM but different FM, or identical FM but different
FFM [32]. Individual height variations in relation to FFM are not
taken into account. In the general population the percentage of fat
mass is an acceptable approximation but in AN, FM and FFM are
not affected to the same extent due to the variable impact of
factors such as physical activity, vomiting, laxative abuse and diet
[14,33]. Thus in the study by VanItally et al., [34] adjustment of
FM and FFM on height was used to enable independent
evaluation of both FM and FFM relative to stature: FFMI= FFM
(kg)/ht (m2) and FMI= FM (kg)/ht (m2).
FFMI and FMI are relevant in studies comparing patients with
controls, and also to determine new reference data on body
composition [32]. In the present study, FFMI and FMI were used
for FM and FFM because we believe that adjustment for height in
a heterogeneous sample like ours is essential for unambiguous
comparison.
Albumin and prealbumin: Blood samples were collected from all
patients in each center on the day of admission to inpatient
treatment. Albumin and prealbumin values were adjusted and
expressed as ratio relative to the normal value on the basis of
average standard values and testing methods for each centres.
Treatment: Information on current medication (at inclusion in
the study) was collected from the medical teams in each centre for
each patient. Antidepressants were selective serotonin reuptake
inhibitors and anxiolytics were benzodiazepines and antihista-
mines.
Statistical Analysis
Statistical analysis was performed on SPSS 17.0. First descrip-
tive statistics were produced. Results are presented as means (SD).
The relationships between the different psychological scores (BDI,
HAD depression, HAD anxiety, MOCI and LSAS) and the
nutritional status indicators (BMI, FFMI, FMI, severity of weight
loss, albumin and prealbumin levels) were tested using Pearson’s
correlations. A statistical significance was considered when p was
,0.05. Potential confounding factors (minimum lifetime BMI, age
and duration of illness) that might affect psychological symptoms
and nutritional status, were also included in the analyses Student t-
tests were performed in order to check for differences in nutritional
status in relation to potential confounding factors such as
restrictive and binge/purging AN, presence/absence of drug
treatment (antidepressants, anxiolytics). Following this, multiple
linear regression models were run in order to test the link between
psychiatric scale scores and the nutritional status indicators,
adjusting on all confounding factors identified by univariate
analysis. Thus each of the psychological scores was a dependent
variable, and the model had the following independent variables:
age, medication (antidepressants and anxiolytics) for adjustment,
and BMI, FFMI, FMI, severity of weight loss, albumin level and
prealbumin level as nutritional indicators.
Results
Sample Characteristics
We recruited 155 subjects, 74 patients were restrictive-AN type
(AN-R) (47.7%) and 81 were binging-purging-AN type (AN-BP)
(52.3%). Concerning medication, 70 patients (45.2%) were not
receiving any antidepressant or anxiolytic treatment, 57 patients
(36.8%) were on antidepressants, 60 patients (38.7%) were on
anxiolytics, and 32 patients (20.6%) were on both antidepressants
and anxiolytics (percentage is above 100 as some of the patients
are counted in more than one group).
The clinical characteristics of all 155 subjects at inclusion are
presented in table 1.
Global scores for the psychological scales are presented in
table 2. For example the BDI average score is 26.8 for our AN
sample. In the BDI, 0–9 indicates minimal depression, 10–18
indicates mild depression, 19–29 indicates moderate depression
and 30–63 indicates severe depression [20]. The LSAS average
score was 57.7 for the fear/anxiety items alone (without summing
responses), which puts these patients in the severe social phobia
category [35].
Relationship Between Psychological Symptoms and
Malnutrition Indicators
No correlation was found between the nutritional markers at
inclusion (i.e. BMI, fat-free mass index, fat mass index, or severity
of weight loss) with any of the psychological scores Albumin levels
were negatively correlated to LSAS scores (p = 0.004; r =20.247).
1. Potential confounding factors
Patients’ psychological scores and nutritional status indicators
were correlated with AN subtype, type of treatment, age, and
Table 1. Patient (n = 155) characteristics at inclusion.
Mean SD Minimum Maximum
Age (years) 20.90 6.16 13.16 43.76
Inclusion BMI (kg/m2) 14.43 1.46 10.72 18.51
Minimum lifetime BMI
(kg/m2)
13.05 1.55 8.59 18.51
Maximum lifetime BMI
(kg/m2)
20.08 3.24 13.15 32.47
Severity of weight loss 5.82 3.22 0 17.94
Duration of illness (years) 4.29 4.71 0.12 24.39
FFMI+ 12.54 0.8 10.68 15.03
FMI+ 1.92 1.14 20.53* 5.10
Albumin level# 1.02 0.16 0.70 1.53
Prealbumin level# 0.81 0.21 0.06 1.36
BMI: Body Mass Index; SD: Standard Deviation.
*Negative values are due to negative body fat predicted values because of the
severe emaciation of AN patients.
+FFMI and FMI are obtained for 146 patients.
#Albumin and prealbumin were measured for 132 patients.
doi:10.1371/journal.pone.0049380.t001
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minimum lifetime BMI. Only significant results are reported,
details can be requested from the authors.
AN-BP and AN-R had no significant difference in psychometric
scores. Differences in body composition and BMI are shown in
table 3.
Patients on antidepressants were significantly older than those
who were not (22.466.4 versus 20.065.9; p = 0.013), they had
longer duration of illness (respectively 5.4465.17 versus
3.5364.27; p = 0.015) and they had significantly higher levels of
depression measured on both the BDI (respectively 32.49611.15
versus 23.42610.75; p = 0.000) and the HADs (respectively
11.2264.32 versus 8.3664.31; p = 0.000); they had higher levels
of anxiety (respectively 14.0163.9 versus 11.7264.40; p= 0.001)
obsessive disorders (respectively 13.9165.78 versus 11.7065.68;
p = 0.023) and social phobia (respectively 64.17615.35 versus
53.96614.96; p = 0.000). Lower albumin levels were detected for
patients on antidepressant treatment than for those without
antidepressants (respectively 0.9860.16 versus 1.0460.15;
p = 0.035).
Compared to patients without anxiolytic treatment patients on
anxiolytics had higher levels of depression measured by both the
BDI (respectively 29.72611.02 versus 24.95611.83; p= 0.014)
and the HADs (respectively 10.7264.34 versus 8.6264.46;
p = 0.005).
Age was highly correlated to duration of illness in our sample
(p = 0.000, r = 0.668) so we adjusted our comparison on age but
not on duration of illness. Correlations between age, duration of
illness and psychological scores, BMI and body composition are
shown in table 4.
Minimum lifetime BMI was not correlated to any of the
psychological scores.
Finally only age and medication, but not subtype of AN nor
minimum lifetime BMI, were introduced into the multivariate
analysis as confounding factors because they were the only 2
factors that affected the psychological scores.
Multivariate analysis
None of the psychological scores were explained by the
nutritional indicators except for a negative correlation between
albumin level and the LSAS fear scale (p = 0.024; beta =20.225),
as in the univariate analysis. Only antidepressants explained the
variability in BDI scores (p = 0.029; beta = 0.228) and anxiolytics
explained the variability in the HADs depression scores (p = 0.037;
beta = 0.216).
Discussion
The present study has adopted a very novel approach to
investigating the relationship between nutritional status and
psychological symptoms in AN, since it takes into account body
composition and biological markers, and not solely weight or BMI,
for the nutritional assessment, also adjusting for age and
psychotropic treatment. To our knowledge it is the largest study
on this topic in AN.
The most important finding of this study of a large sample of
severe AN patients is that we did not identify any correlation
between the level of depression, anxiety or Obsessive-compulsive
disorder (OCD) and any measure of current nutritional status at
inclusion, even when taking into account potential confounding
factors (age and current psychotropic treatment). This is an
unexpected result. Scores for the intensity of depression were
however related to the presence of psychotropic treatment and in
certain cases to age or duration of illness (univariate analysis).
Three main hypotheses might explain our results that failed to
reveal any correlation between the nutritional status and the
psychological symptoms that we measured.
First of all, although we studied a large sample, the subjects’
characteristics might have been largely homogeneous in terms of
the severity of malnutrition and the reported psychological
symptoms, so that we could not identify any relationship between
them. Patients were evaluated at admission to inpatient treatment
at the most (or one of the most) severe moments in their illness. For
example the narrow SD for BMI (mean= 14.43; SD=1.45) shows
the severe malnutrition and the relative homogeneity in the
sample. Even the patients that had higher BMI had lost huge
amounts of weight (Cf. methods) and thus were all severely
malnourished. Consequently there was very little variation in the
degree of malnutrition. Despite the fact that levels of depression
and anxiety were variable, we were not able to establish any link
Table 2. Psychlogical scores at inclusion.
Mean SD Minimum Maximum
BDI 26.80 11.73 3.00 53.00
HAD depression 9.43 4.52 .00 18.00
HAD anxiety 12.58 4.35 2.00 21.00
MOCI 12.53 5.80 1.00 28.00
LSAS 57.73 15.85 26.00 95.00
SD: standard deviation; BDI : Beck Depression Inventory, HAD: Hospital Anxiety
and Depression scale, MOCI : Maudsley Obsessive-Compulsive Inventory, LSAS:
Liebowitz social anxiety scale.
doi:10.1371/journal.pone.0049380.t002
Table 3. Differences and means of BMI and body composition components between AN-R and AN-BP.
Mean±SD AN-R (N=74) Mean±SD AN-BP (N=80) p
Inclusion BMI (kg/m2) 14.0161.16 14.861.6 0.001
Minimum lifetime BMI (kg/m2) 12.661.25 13.4661.68 0.000
Maximum lifetime BMI (kg/m2) 19.4963.34 20.6363.05 0.03
FMI+ 1.6160.91 2.2161.25 0.001
FFMI+ 12.4360.71 12.6460.83 0.3
AN-R: Anorexia Nervosa Restrictive type.
AN-BP: Anorexia Nervosa Binge Purging type.
BMI: Body Mass Index; SD: Standard Deviation.
+FFMI and FMI are obtained for 146 patients.
doi:10.1371/journal.pone.0049380.t003
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with levels of malnutrition. There may be a nutrition threshold,
whereby psychological state is only affected when a certain degree
of nutritional deficiency has been reached.
Second, we evaluated nutritional status in more comprehensive
manner and in a larger sample compared to previous studies, and
we used relatively a large set of indicators. However, body
composition was measured using the BIA which is not a reference
method (such as Dual-emission X-ray absorptiometry (DXA) or
measurements using 4 compartment models). The severely
malnourished status of the patients did not enable transfer to
DXA centres for the measures to be performed. Also, the severity
of malnutrition was measured by a rough estimation of the
difference between the highest lifetime BMI and BMI at inclusion,
thus considering weight loss to be linear, and not accounting for
duration of illness and weight fluctuations. A more precise
measure of these variations should be performed to provide
information on this subject.
Third, as hypothesised by certain authors [36,37] depression in
AN, rather than having a single aetiology, is likely to be the
consequence of various factors; depressive and anxiety symptoms
in severely malnourished AN patients could therefore be mainly
due to factors other than malnutrition, such as depressive
symptoms linked to exhaustion, chronic illness or in some cases
premorbid depression.
An interesting yet worrying observation from our study was the
frequent use of psychotropic drugs in the treatment of very
malnourished patients. More than 36% percent of AN patients
admitted were receiving antidepressants. This is unusual, espe-
cially in severely malnourished subjects: it is well established that
antidepressants are not effective on patients with low BMI [2].
These treatments have usually been prescribed before inpatient
admission, generally by non-specialized physicians, and they are
generally stopped after admission, because they are ineffective.
Despite these elements, it is interesting to see that the higher the
anxiety or depressive scores, the more likely patients are to be
receiving anti-depressants (AD).
How can we understand the link between psychological
symptoms and malnutrition in the light of our data and the
literature?
In the first stages of the illness, patients report that starvation
provides relief from pre-existing anxiety and depressive symptoms.
However, in a second stage, these symptoms tend to increase and
regardless if malnutrition and starvation continue. If at the
beginning of the illness, patients feel better and less anxious
although they are starving, this might be due to complex biological
and psychological mechanisms: depletion in tryptophan resulting
from a strict diet could relieve anxiety, as suggested by Kaye et al.
[38]. In addition, other effects such as satisfaction at having lost
weight, positive reinforcement from peers [39], or battling against
hunger as a source of pleasure and control [40], enable them to
experience a degree of ‘‘well-being’’. However, with time, these
effects fade and anxiety and depression re-emerge, along with
other rituals and obsessions. It is at this stage that patients are
usually admitted to hospitalization. This anxio-depressive recru-
descence is also explained by several other factors: the regulation
and adaptation of the body to all kinds of nutritional deficiencies
and hormonal changes, negative comments concerning extreme
thinness, exhaustion, chronicity of the illness and the hospitaliza-
tion itself. Thus the patient can be caught in a vicious circle that
drives him/her to ever-lower BMI, sometimes fatal. In fact, the
patient adopts again the first strategy, which is starvation, in an
attempt to decrease anxiety and depression, as at the beginning of
the illness. Unfortunately, this strategy aggravates the anxiety and
depression and the vicious circle described by Garner described
[39] becomes established.
Conclusions
The present study is a pioneer investigation of relationships
between various nutritional indicators and psychological symp-
toms in severely malnourished AN patients. In contrast with
theories set out in the literature, we did not identify any
correlations between severely malnourished status and psycholog-
ical symptoms. However these results suggest several lines of
research to confirm this finding. The use of even better nutritional
indicators is needed, for example DXA instead of BIA for body
composition analysis, and other than albumin and prealbumin
proteins as serum markers [41]. The development of a precise
measure of the scale of weight loss could be beneficial. Screening
for vitamin and minerals levels could also help to distinguish
symptoms resembling depression or anxiety, such as irritability,
moodiness, restlessness, etc, associated with malnutrition (vitamin
deficiencies, mineral depletion and decreased food intake [42–45]).
These could mediate the effect of malnutrition on psychological
symptoms more markedly than the variables explored in this
study. Clinicians and the treating team of AN, should be aware
that there could be confusion in the aetiology of certain
malnutrition symptoms that appear as depression and anxiety
symptoms.
The cornerstone of treating AN is still nutrition rehabilitation
which should be initiated immediately [2]. Nutrition rehabilitation
should start first in order to decrease immediately physical
complications and psychological well-being. In practice managing
co-occurent anxiety or depression symptoms in ED patients will
include the specific treatment of ED, that could lower a part of
anxiety and depressive symptoms by nutrition rehabilitation,
withdrawal from binges and purges, specific psychotherapy
(individual or family therapy) and work on the social impact of
the illness.
Table 4. Correlations between age, duration of illness and BMI, body composition components and psychological scores.
Age
Inclusion BMI
(kg/m2)
Duration
of illness FFMI FMI
HAD
anxiety
HAD
depression BDI LSAS MOCI
Age r 1 2.002 .668* 2.239* 2.239* .173* .195* .155* .210* 2.008*
p .980 .000 .004 .004 .033 .0016 .055 .009 .919
Duration of illness r .668* .002 1 2.238* 2.238* .174* .236* .212* .250* .034*
p .000 .980 .004 .004 .032 .003 .009 .002 .680
BDI : Beck Depression Inventory, HAD: Hospital Anxiety and Depression scale, MOCI : Maudsley Obsessive-Compulsive Inventory, LSAS: Liebowitz social anxiety scale;
BMI: Body Mass Index; SD: Standard Deviation;
+FFMI and FMI are obtained for 146 patients.
doi:10.1371/journal.pone.0049380.t004
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Future studies with a longitudinal design and a follow up on the
evolution during treatment are needed to explore variations in
nutritional status in relation to psychological symptoms using more
heterogeneous samples. For instance, future research should
consider including a group of healthy controls or a group of
recovered subjects, and the use of further assessment scales for
psychological symptoms. More studies are needed to confirm our
results.
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